WHO: Genomic Studies Skewed Towards Rich Nations, LMICs Under 5%

WHO: Genomic Studies Skewed Towards Rich Nations, LMICs Under 5%

A new WHO analysis reveals that less than 5% of disease-focused genomic studies are conducted in low and middle-income countries, while over 80% are concentrated in high-income nations. This significant disparity highlights major equity gaps in global health research. The report urges increased investment and more inclusive research in underserved regions.

Read the full story on Quick Digest.